XML 90 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes - Schedule of Significant Components of Company's Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Assets        
Acquired in-process research and development $ 35,337 $ 45,938    
Net operating loss carryforward 45,917 6,370    
Accrued compensation 19,915 11,551    
Lease obligations, net   71    
Fixed assets 173 115    
Inventory 5,344 6,781    
Accrued rebates 3,791 7,118    
Research and development 38,799 8,802    
Other 1,132 15    
Total 150,408 86,761    
Net deferred tax asset 149,612 85,943    
Valuation allowance (5,450)   $ (96,366) $ (102,874)
Total 144,162 85,943    
Liabilities        
Lease obligations, net 6      
Other 790 818    
Total $ 796 $ 818